FDA OKs New Treatment to Prevent COVID in High-Risk People

United States News News

FDA OKs New Treatment to Prevent COVID in High-Risk People
United States Latest News,United States Headlines
  • 📰 WebMD
  • ⏱ Reading Time:
  • 34 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 17%
  • Publisher: 51%

A new antibody treatment has been approved to help prevent COVID-19, and it will be available in a matter of days for many of the estimated 3 in every 100 people in the U.S. who have compromised immune systems.

March 26, 2024 – The FDA has approved a new antibody treatment to help prevent COVID-19 in those who are most at risk from the virus., the agency explained that the new treatment can be used preventively for immunocompromised people ages 12 and older who aren’t currently infected with the virus that causes COVID and haven’t recently been exposed.

Called Pemgarda, the monoclonal antibody helps prevent the virus from attaching to human cells and is given through an IV. It cannot be given within 2 weeks of a person receiving a COVID vaccine. Pemgarda received an emergency use authorization from the FDA. In a letter to drugmaker Invivyd, the FDA requested more data from the ongoing phase III clinical trial studying the drug.

The study also showed that the highest risk for hospitalization, ICU admission, or death due to COVID was among people who had received solid organ transplants, have a disorder that weakens their immune system, have received stem cell treatments, or had blood cancer.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

WebMD /  🏆 709. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

FDA OKs First Gene Therapy for Metachromatic LeukodystrophyFDA OKs First Gene Therapy for Metachromatic LeukodystrophyAtidarsagene autotemcel (Lenmeldy) is approved for presymptomatic late infantile, presymptomatic early juvenile, or early symptomatic early juvenile MLD.
Read more »

FDA OKs Givinostat for Duchenne Muscular DystrophyFDA OKs Givinostat for Duchenne Muscular DystrophyGivinostat (Duvyzat), a histone deacetylase inhibitor, is the first nonsteroidal drug approved to treat patients aged 6 years or older with all genetic variants of DMD.
Read more »

With eyes on warehouse safety, California board OKs new indoor heat rulesWith eyes on warehouse safety, California board OKs new indoor heat rulesThe Department of Finance is objecting to Cal/OSHA’s rules, citing concerns about huge costs to warehouses and correctional facilities.
Read more »

At Citizens Bank Park, new season, new bites: hoagies, new Schwarburger, ‘Always Sunny’ whiskey and moreAt Citizens Bank Park, new season, new bites: hoagies, new Schwarburger, ‘Always Sunny’ whiskey and morePhillies are bringing exciting new concessions to Citizens Bank Park, including hoagies and 'It's Always Sunny in Philadelphia' whiskey.
Read more »

FDA Says Never Take These OTC Medications Before Driving in New AlertFDA Says Never Take These OTC Medications Before Driving in New AlertDigital destination for sophisticated men & women. Live your best life with expert tips and news on health, food, sex, relationships, fashion and lifestyle.
Read more »

New FDA-approved treatment for atrial fibrillation being used on Chicago-area patientsNew FDA-approved treatment for atrial fibrillation being used on Chicago-area patientsA new FDA-approved treatment for atrial fibrillation, a common heart condition impacting millions of Americans, is now being used on Chicago-area patients at…
Read more »



Render Time: 2025-02-27 11:20:31